Icu Medical Stock Performance
| ICUI Stock | USD 138.03 1.61 1.15% |
The firm retains a Market Volatility (i.e., Beta) of 1.16, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ICU Medical will likely underperform. At this point, ICU Medical has a negative expected return of -0.23%. Please make sure to check out ICU Medical's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if ICU Medical performance from the past will be repeated at future time.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days ICU Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (0.64) | Five Day Return 0.35 | Year To Date Return (11.61) | Ten Year Return 55.22 | All Time Return 2.9 K |
Last Split Factor 3:2 | Last Split Date 2002-03-18 |
1 | ICU Medical Inc Announces Fourth Quarter 2024 Earnings Release and Conference Call | 02/13/2025 |
2 | Acquisition by Vivek Jain of 12000 shares of ICU Medical at 88.76 subject to Rule 16b-3 | 02/21/2025 |
3 | ICU Medical Inc Q4 2024 Earnings Call Highlights Strong Revenue Growth and Strategic ... | 02/28/2025 |
4 | ICU Medical Inc Announces Participation in KeyBanc Healthcare Forum | 03/07/2025 |
5 | Disposition of 1073 shares by Virginia Sanzone of ICU Medical subject to Rule 16b-3 | 03/10/2025 |
6 | Victory Capital Management Inc. Trims Stake in ICU Medical, Inc. - Defense World | 03/12/2025 |
7 | Disposition of 2923 shares by Daniel Woolson of ICU Medical subject to Rule 16b-3 | 03/14/2025 |
8 | ICU Medical Inc to Present at 24th Annual Needham Virtual Healthcare Conference | 03/24/2025 |
9 | United States Home Infusion Market Forecast Report and Company Analysis 2025-2033 Featuring Baxter, BD and Co, Eli Lilly, Fresenius, ICU Medical, Option Care He... | 03/27/2025 |
10 | ICU Medical Infusion Assessment Program Earns INS Seal of Approval - MarketScreener | 04/01/2025 |
11 | ICU Medical Inc Unveils New Precision IV Pumps with FDA Clearance | 04/07/2025 |
12 | ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts | 04/09/2025 |
13 | Unpacking Q4 Earnings Artivion In The Context Of Other Medical Devices Supplies - Cardiology, Neurology, Vascular Stocks | 04/15/2025 |
| Begin Period Cash Flow | 254.2 M |
ICU Medical Relative Risk vs. Return Landscape
If you would invest 16,607 in ICU Medical on January 16, 2025 and sell it today you would lose (2,643) from holding ICU Medical or give up 15.91% of portfolio value over 90 days. ICU Medical is currently does not generate positive expected returns and assumes 3.0474% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than ICU, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ICU Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ICU Medical, and traders can use it to determine the average amount a ICU Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0753
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ICUI |
Estimated Market Risk
| 3.05 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ICU Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ICU Medical by adding ICU Medical to a well-diversified portfolio.
ICU Medical Fundamentals Growth
ICU Stock prices reflect investors' perceptions of the future prospects and financial health of ICU Medical, and ICU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ICU Stock performance.
| Return On Equity | -0.0576 | ||||
| Return On Asset | 0.0142 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 4.77 B | ||||
| Shares Outstanding | 24.61 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.75 X | ||||
| Price To Sales | 1.44 X | ||||
| Revenue | 2.38 B | ||||
| Gross Profit | 824.78 M | ||||
| EBITDA | 42.96 M | ||||
| Net Income | (117.69 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.58 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 80.16 X | ||||
| Cash Flow From Operations | 204.03 M | ||||
| Earnings Per Share | (4.83) X | ||||
| Market Capitalization | 3.44 B | ||||
| Total Asset | 4.2 B | ||||
| Retained Earnings | 690.16 M | ||||
| Working Capital | 885.8 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
About ICU Medical Performance
By evaluating ICU Medical's fundamental ratios, stakeholders can gain valuable insights into ICU Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ICU Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ICU Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 137.04 | 72.68 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.06) | (0.06) |
Things to note about ICU Medical performance evaluation
Checking the ongoing alerts about ICU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ICU Medical generated a negative expected return over the last 90 days | |
| ICU Medical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 824.78 M. | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Unpacking Q4 Earnings Artivion In The Context Of Other Medical Devices Supplies - Cardiology, Neurology, Vascular Stocks |
- Analyzing ICU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Medical's stock is overvalued or undervalued compared to its peers.
- Examining ICU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Medical's stock. These opinions can provide insight into ICU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance |